TU Dresden

Dynamics and mechanisms of cell renewal: Dr. Olaf Bergmann supports neurodegeneration research at the CRTD
On November 1st 2016, Dr. Olaf Bergmann started as a research group leader at the CRTD. Dr. Bergmann focuses on organ systems that show a low level of regenerative capacity, such as the human brain... [read more]
© Ting-Di Wu, Jean-Luc Guerquin-Kern, Olaf Bergmann
Professor Michael Brand honored with the Order of Merit of Germany
Professor Michael Brand, research group leader and founding director of the CRTD, has been honored with the Order of Merit of Germany for his extraordinary scientific work in the fields of stem cell... [read more]
© Matthias Rietschel
Tracking down bone regeneration: Research team at the CRTD identifies the cells that form new bone during Axolotl finger regeneration
At the DFG-Center for Regenerative Therapies Dresden (CRTD) - Cluster of Excellence at the TU Dresden, a team of researchers lead by Joshua Currie, PhD, and Elly Tanaka, PhD, used live imaging... [read more]
© Joshua Currie, PhD
Annual CRTD/BIOTEC Master Graduation Ceremony on October 28
CRTD/BIOTEC Master's graduates received their certificates and mortarboards at the annual Graduation Ceremony [read more]

At the DFG-Center for Regenerative Therapies Dresden (CRTD), our mission is to understand the biology of stem cells and physiological and pathological tissue and organ repair in order to develop new treatments for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease, haematological diseases, such as leukemia, metabolic diseases, such as diabetes, and bone diseases. Our scientists are encouraged to think outside the box and to explore untapped areas of knowledge in the regenerative potential of the human body, and to apply this knowledge to prevent or reverse disease processes.

To achieve our aims, we strongly support interdisciplinary research, with eighteen core groups in a network of 87 principal investigators from diverse research institutes on the Dresden campus, with expertise in everything from the biology of cells and tissues to biomaterials to nanoengineering. CRTD has become a major driving force on campus and is ready to meet the challenges of moving new interventional strategies from bench to bedside.